We are live on ! Find out more
CTSO icon

Cytosorbents Corp

85 hedge funds and large institutions have $69.9M invested in Cytosorbents Corp in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more call options, than puts

Call options by funds: $450K | Put options by funds: $172K

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

8% more funds holding

Funds holding: 7985 (+6)

1.3% more ownership

Funds ownership: 26.06%27.35% (+1.3%)

9% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 22

34% less capital invested

Capital invested by funds: $106M → $69.9M (-$35.8M)

Holders
85
Holders Change
+6
Holders Change %
+7.59%
% of All Funds
1.89%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
24
Reduced
22
Closed
11
Calls
$450K
Puts
$172K
Net Calls
+$278K
Net Calls Change
-$287K
Name Holding Trade Value Shares
Change
Change in
Stake
GIP
26
Granite Investment Partners
California
$476K
TCIM
27
TIAA CREF Investment Management
New York
$454K -$6.7K -675 -1%
Wells Fargo
28
Wells Fargo
California
$452K +$153K +15,409 +38%
CPP
29
Crow Point Partners
Massachusetts
$380K +$5.71K +575 +1%
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$366K
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$356K
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$308K +$134K +13,505 +55%
Creative Planning
33
Creative Planning
Kansas
$275K
Two Sigma Investments
34
Two Sigma Investments
New York
$271K +$197K +19,843 +145%
AQR Capital Management
35
AQR Capital Management
Connecticut
$265K
Goldman Sachs
36
Goldman Sachs
New York
$262K +$89.4K +9,006 +38%
Invesco
37
Invesco
Georgia
$259K -$1.88M -189,787 -86%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$255K
UBS Group
39
UBS Group
Switzerland
$253K +$80.5K +8,108 +35%
AG
40
Advisor Group
Arizona
$219K +$31.4K +3,160 +13%
ARTA
41
A.R.T. Advisors
New York
$216K +$265K +26,703 New
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$174K +$214K +21,583 New
AIG
43
American International Group
New York
$158K -$1.49K -150 -0.8%
Commonwealth Equity Services
44
Commonwealth Equity Services
Massachusetts
$148K -$1.99K -200 -1%
Mariner
45
Mariner
Kansas
$123K
KM
46
Kalos Management
Georgia
$120K
MIM
47
MetLife Investment Management
New Jersey
$119K
ACM
48
Aviance Capital Management
Florida
$111K +$136K +13,704 New
Barclays
49
Barclays
United Kingdom
$109K +$15.1K +1,517 +13%
SIC
50
Salem Investment Counselors
North Carolina
$105K

CTSO Hedge Fund Activity: Q4 2018 in Review

85 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2018, worth a combined $69.9M — down 34% from $106M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CTSO positions and 11 closed out — a net gain of 7 holders — while 24 added to existing stakes and 22 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.21M. The largest seller was Invesco, cutting an estimated $1.88M.

  • 85 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2018, up from 79 in Q3 2018.
  • Funds reported $69.9M of Cytosorbents Corp stock for Q4 2018, down 34% quarter-over-quarter.
  • 18 funds opened new Cytosorbents Corp positions in Q4 2018 and 11 closed out, a net change of +7 holders.
  • The largest Cytosorbents Corp buyer in Q4 2018 was Renaissance Technologies, an estimated $1.21M added.
  • The largest Cytosorbents Corp seller in Q4 2018 was Invesco, an estimated $1.88M sold.

Based on aggregated 13F filings for Q4 2018.